Immediate sequential bilateral intravitreal injections: an Indian perspective

Koushik Tripathy Department of Vitreoretina and Uvea, ICARE Eye Hospital and Postgraduate Institute, Sector-26, Noida, Uttar Pradesh, IndiaRecently, Ruão et al1 have shown in a study spanning 6 years that only 1 of 6560 (0.015%) eyes undergoing unilateral intravitreal anti-vascular endot...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Tripathy K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	Avastin Bevacizumab Lucentis Ranibizumab Eylea Aflibercept endophthalmitis Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/601af6f9f7224b14a29dae9a3be40763
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:601af6f9f7224b14a29dae9a3be40763
record_format	dspace
spelling	oai:doaj.org-article:601af6f9f7224b14a29dae9a3be407632021-12-02T00:42:40ZImmediate sequential bilateral intravitreal injections: an Indian perspective1177-5483https://doaj.org/article/601af6f9f7224b14a29dae9a3be407632017-04-01T00:00:00Zhttps://www.dovepress.com/letter-safety-of-bilateral-same-day-intravitreal-injections-of-an-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Koushik Tripathy Department of Vitreoretina and Uvea, ICARE Eye Hospital and Postgraduate Institute, Sector-26, Noida, Uttar Pradesh, IndiaRecently, Ruão et al1 have shown in a study spanning 6 years that only 1 of 6560 (0.015%) eyes undergoing unilateral intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection developed culture-proven endophthalmitis. None of the 1612 eyes receiving immediate sequential bilateral intravitreal treatment (ISBIVT) with anti-VEGF injection developed endophthalmitis.1 Likewise, immediate sequential bilateral cataract surgery (ISBCS)2 has been proposed to provide “potentially decreased wait times for surgery, patient convenience and cost savings for health care payors”, with comparable visual outcomes and complication rates. However, in an Indian scenario, there is need for discussion regarding endophthalmitis following ISBIVT injections.View the original paper by Ruão and colleagues.Tripathy KDove Medical PressarticleAvastinBevacizumabLucentisRanibizumabEyleaAfliberceptendophthalmitisOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 639-640 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Avastin Bevacizumab Lucentis Ranibizumab Eylea Aflibercept endophthalmitis Ophthalmology RE1-994
spellingShingle	Avastin Bevacizumab Lucentis Ranibizumab Eylea Aflibercept endophthalmitis Ophthalmology RE1-994 Tripathy K Immediate sequential bilateral intravitreal injections: an Indian perspective
description	Koushik Tripathy Department of Vitreoretina and Uvea, ICARE Eye Hospital and Postgraduate Institute, Sector-26, Noida, Uttar Pradesh, IndiaRecently, Ruão et al1 have shown in a study spanning 6 years that only 1 of 6560 (0.015%) eyes undergoing unilateral intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection developed culture-proven endophthalmitis. None of the 1612 eyes receiving immediate sequential bilateral intravitreal treatment (ISBIVT) with anti-VEGF injection developed endophthalmitis.1 Likewise, immediate sequential bilateral cataract surgery (ISBCS)2 has been proposed to provide “potentially decreased wait times for surgery, patient convenience and cost savings for health care payors”, with comparable visual outcomes and complication rates. However, in an Indian scenario, there is need for discussion regarding endophthalmitis following ISBIVT injections.View the original paper by Ruão and colleagues.
format	article
author	Tripathy K
author_facet	Tripathy K
author_sort	Tripathy K
title	Immediate sequential bilateral intravitreal injections: an Indian perspective
title_short	Immediate sequential bilateral intravitreal injections: an Indian perspective
title_full	Immediate sequential bilateral intravitreal injections: an Indian perspective
title_fullStr	Immediate sequential bilateral intravitreal injections: an Indian perspective
title_full_unstemmed	Immediate sequential bilateral intravitreal injections: an Indian perspective
title_sort	immediate sequential bilateral intravitreal injections: an indian perspective
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/601af6f9f7224b14a29dae9a3be40763
work_keys_str_mv	AT tripathyk immediatesequentialbilateralintravitrealinjectionsanindianperspective
_version_	1718403499199299584

Immediate sequential bilateral intravitreal injections: an Indian perspective

Ejemplares similares